IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 46
Titolo Data di pubblicazione Autore(i) File
Novel small molecules for PPARs modulation and their potential use for treatment of metabolic disorders 1-gen-2019 Laghezza, Antonio; Brunetti, Leonardo; Piemontese, Luca; Tortorella, Paolo; Loiodice, Fulvio
Identification of Natural Scaffolds as New Multi-Functional Agents for the Treatment of Alzheimer’s Disease 1-gen-2019 Laghezza, Antonio; Brunetti, Leonardo; Capriati, Vito; Catto, Marco; Loiodice, Fulvio; Tortorella, Paolo; Piemontese, Luca; Solfrizzo, Michele
Natural compounds as FAAH inhibitors: preliminary screening and potential developments 1-gen-2019 Brunetti, L.; Laghezza, A.; Loiodice, F.; Piemontese, L.; Tortorella, P.
Peroxisome Proliferator Activated Receptor (PPAR) agonists as Fatty Acid Amide Hydrolase (FAAH) inhibitors: screening and preliminary structure-activity relationships 1-gen-2019 Brunetti, Leonardo; Laghezza, Antonio; Piemontese, Luca; Tortorella, Paolo; Loiodice, Fulvio
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation 1-gen-2019 Brunetti, Leonardo; Loiodice, Fulvio; Piemontese, Luca; Tortorella, Paolo; Laghezza, Antonio
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 1-gen-2020 Leuci, Rosalba; Brunetti, Leonardo; Laghezza, Antonio; Loiodice, Fulvio; Tortorella, Paolo; Piemontese, Luca
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 1-gen-2020 Brunetti, Leonardo; Carrieri, Antonio; Piemontese, Luca; Tortorella, Paolo; Loiodice, Fulvio; Laghezza, Antonio
Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2‐Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil‐Like Compounds 1-gen-2020 Piemontese, L.; Sergio, R.; Rinaldo, F.; Brunetti, L.; Perna, F. M.; Amelia Santos, M.; Capriati, V.
Bone-seeking matrix metalloproteinase inhibitors for the treatment of skeletal malignancy 1-gen-2020 Laghezza, A.; Piemontese, L.; Brunetti, L.; Caradonna, A.; Agamennone, M.; Di Pizio, A.; Pochetti, G.; Montanari, R.; Capelli, D.; Tauro, M.; Loiodice, F.; Tortorella, P.
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease 1-gen-2020 Brunetti, Leonardo; Laghezza, Antonio; Loiodice, Fulvio; Tortorella, Paolo; Piemontese, Luca
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders 1-gen-2020 Leuci, Rosalba; Brunetti, Leonardo; Laghezza, Antonio; Tortorella, Paolo; Loiodice, Fulvio; Piemontese, Luca
DEVELOPMENT OF PHENOXYALKYLPIPERIDINES AS HIGH-AFFINITY SIGMA-1 (s1) RECEPTOR LIGANDS WITH POTENT ANTI-AMNESIC ACTIVITY 1-gen-2021 Laghezza, Antonio; Abatematteo, Francesca S.; Mosier, Philip D.; Niso, Mauro; Brunetti, Leonardo; Berardi, Francesco; Loiodice, Fulvio; Contino, Marialessandra; Delprat, Benjamin; Maurice, Tangui; Abate, Carmen
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 1-gen-2021 Poliseno, Viviana; Chaves, Sílvia; Brunetti, Leonardo; Loiodice, Fulvio; Carrieri, Antonio; Laghezza, Antonio; Tortorella, Paolo; Magalhães, João D.; Cardoso, Sandra M.; Santos, M. Amélia; Piemontese, Luca
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 1-gen-2021 Leuci, Rosalba; Brunetti, Leonardo; Poliseno, Viviana; Laghezza, Antonio; Loiodice, Fulvio; Tortorella, Paolo; Piemontese, Luca
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 1-gen-2021 Laghezza, A.; Piemontese, L.; Brunetti, L.; Caradonna, A.; Agamennone, M.; Loiodice, F.; Tortorella, P.
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 1-gen-2021 Brunetti, Leonardo; Leuci, Rosalba; Carrieri, Antonio; Laghezza, Antonio; Catto, Marco; Piemontese, Luca; Tortorella, Paolo; Loiodice, Fulvio
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 1-gen-2021 Leuci, R.; Brunetti, L.; Carocci, A.; Carrieri, A.; Catto, M.; Laghezza, A.; Tortorella, P.; Piemontese, L.; Loiodice, F.
Novel Rivastigmine-Based Multitarget Hybrids For Potential Treatment of Alzheimer’s Disease: Cu(II) And Fe(III) Chelation Studies 1-gen-2022 Vicente-Zurdo, David; Brunetti, Leonardo; Piemontese, Luca; Madrid, Yolanda; Chaves, Sílvia; Amélia Santos., M.
Novel rivastigmine structure-based hybrids for the potential treatment of Alzheimer’s disease 1-gen-2022 Leuci, R.; Brunetti, L.; Carrieri, A.; Catto, M.; Laghezza, A.; Tortorella, P.; Loiodice, F.; Piemontese, L.
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 1-gen-2022 Czarnota-Łydka, Kinga; Satała, Grzegorz; Brunetti, Leonardo; Laghezza, Antonio; Piemontese, Luca; DE CANDIA, Modesto; Purgatorio, Rosa; Gumułka, Magdalena; Kucwaj-Brysz, Katarzyna; Carrieri, Antonio; Handzlik, Jadwiga
Mostrati risultati da 1 a 20 di 46
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile